Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children
JM Kemmeren, SS Timmer, NAT van der Maas… - Vaccine, 2011 - Elsevier
Background In 2005, an acellular pertussis-containing DTP-IPV-Hib vaccine for infants
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
[HTML][HTML] Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine …
SM Lee, SJ Kim, J Chen, JH Kim… - Human Vaccines & …, 2019 - Taylor & Francis
ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …
A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults
FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults
K Abarca, F Valdivieso, M Potin, I Ibáñez… - Revista Medica de …, 2002 - europepmc.org
[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …
Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …
SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …
vaccine is recommended in many countries for boosting immunity in adolescents and adults …
Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school …
CL Collins, P Salt, N McCarthy, T Chantler, L Lane… - Vaccine, 2004 - Elsevier
This open, randomised controlled trial studied the immunogenicity and reactogenicity of two
combined low-dose diphtheria, tetanus and acellular pertussis vaccines (Td5aP-IPV …
combined low-dose diphtheria, tetanus and acellular pertussis vaccines (Td5aP-IPV …
Comparative trial to assess the reactogenicity of the diphtheria-tetanusacellular pertussis (DTPa) vaccine plus Haemophilus influenzae type b (Hib) conjugate vaccine …
F Calbo, R Dal-Ré, J Díez-Delgado, S Oña… - Medicina clínica, 2002 - Elsevier
BACKGROUND: The diphtheria-tetanus-whole-cell pertussis (DTPw) vaccine is being
replaced in Western countries, and inseveral Spanish Autonomous Communities, by the …
replaced in Western countries, and inseveral Spanish Autonomous Communities, by the …
Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine
F Zepp, M Knuf, P Habermehl… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
There is increasing interest in prevention of pertussis in adults by vaccination, but little is
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …